176 related articles for article (PubMed ID: 36240260)
41. Acceleration of amyloid fibril formation by carboxyl-terminal truncation of human serum amyloid A.
Tanaka M; Kawakami T; Okino N; Sasaki K; Nakanishi K; Takase H; Yamada T; Mukai T
Arch Biochem Biophys; 2018 Feb; 639():9-15. PubMed ID: 29288051
[TBL] [Abstract][Full Text] [Related]
42. The potassium permanganate method. A reliable method for differentiating amyloid AA from other forms of amyloid in routine laboratory practice.
van Rijswijk MH; van Heusden CW
Am J Pathol; 1979 Oct; 97(1):43-58. PubMed ID: 495695
[TBL] [Abstract][Full Text] [Related]
43. From hexamer to amyloid: marginal stability of apolipoprotein SAA2.2 leads to in vitro fibril formation at physiological temperature.
Wang L; Lashuel HA; Colón W
Amyloid; 2005 Sep; 12(3):139-48. PubMed ID: 16194868
[TBL] [Abstract][Full Text] [Related]
44. Amyloid formation in the rat: adenoviral expression of mouse serum amyloid A proteins.
Yu J; Guo JT; Zhu H; Kindy MS
Amyloid; 2000 Mar; 7(1):32-40. PubMed ID: 10842703
[TBL] [Abstract][Full Text] [Related]
45. Intrinsic Stability, Oligomerization, and Amyloidogenicity of HDL-Free Serum Amyloid A.
Colón W; Aguilera JJ; Srinivasan S
Adv Exp Med Biol; 2015; 855():117-34. PubMed ID: 26149928
[TBL] [Abstract][Full Text] [Related]
46. Structural studies of the C-terminal 19-peptide of serum amyloid A and its Pro → Ala variants interacting with human cystatin C.
Maszota M; Karska N; Spodzieja M; Ciarkowski J; Kołodziejczyk AS; Rodziewicz-Motowidło S; Czaplewska P
J Mol Recognit; 2015 Jul; 28(7):413-26. PubMed ID: 25736604
[TBL] [Abstract][Full Text] [Related]
47. Alveolar hydatid cyst (AHC): inflammation-induced reactive gastrointestinal (GL) amyloidosis in AHC-infected mice and chemical characterization of the GL amyloid.
Li W; Chan SL; Chronopoulos S; Bell A; Ali-Khan Z
Exp Parasitol; 1996 Jun; 83(1):1-10. PubMed ID: 8654537
[TBL] [Abstract][Full Text] [Related]
48. Increased susceptibility of serum amyloid A 1.1 to degradation by MMP-1: potential explanation for higher risk of type AA amyloidosis.
van der Hilst JC; Yamada T; Op den Camp HJ; van der Meer JW; Drenth JP; Simon A
Rheumatology (Oxford); 2008 Nov; 47(11):1651-4. PubMed ID: 18815155
[TBL] [Abstract][Full Text] [Related]
49. Amyloidomas of the nervous system: a monoclonal B-cell disorder with monotypic amyloid light chain lambda amyloid production.
Laeng RH; Altermatt HJ; Scheithauer BW; Zimmermann DR
Cancer; 1998 Jan; 82(2):362-74. PubMed ID: 9445195
[TBL] [Abstract][Full Text] [Related]
50. Establishing the fluorescent amyloid ligand h-FTAA for studying human tissues with systemic and localized amyloid.
Sjölander D; Röcken C; Westermark P; Westermark GT; Nilsson KP; Hammarström P
Amyloid; 2016 Jun; 23(2):98-108. PubMed ID: 26987044
[TBL] [Abstract][Full Text] [Related]
51. Proteomic analysis of highly prevalent amyloid A amyloidosis endemic to endangered island foxes.
Gaffney PM; Imai DM; Clifford DL; Ghassemian M; Sasik R; Chang AN; O'Brien TD; Coppinger J; Trejo M; Masliah E; Munson L; Sigurdson C
PLoS One; 2014; 9(11):e113765. PubMed ID: 25429466
[TBL] [Abstract][Full Text] [Related]
52. Accumulation and absorption of serum amyloid A and apolipoprotein E fragments in the course of AA amyloidosis: a study in a mouse model.
Sato J; Kotani K; Yamada T
Ann Clin Lab Sci; 2014; 44(3):249-53. PubMed ID: 25117094
[TBL] [Abstract][Full Text] [Related]
53. Serum amyloid A protein forms a complex with a fragment of apolipoprotein A-I in the domestic blue fox: a protective mechanism against AA amyloidosis?
Elisen EJ; Bruun CF; Nordstoga K; Husby G; Sletten K
Amyloid; 2004 Sep; 11(3):184-90. PubMed ID: 15523921
[TBL] [Abstract][Full Text] [Related]
54. Deposition, Clearance, and Reinduction of Amyloid A Amyloid in Interleukin 1 Receptor Antagonist Knockout Mice.
Watanabe K; Uchida K; Chambers JK; Ushio N; Nakayama H
Vet Pathol; 2017 Jan; 54(1):99-110. PubMed ID: 27565681
[TBL] [Abstract][Full Text] [Related]
55. Generation and use of site-specific antibodies to serum amyloid A for probing amyloid A development.
Miura K; Ju ST; Cohen AS; Shirahama T
J Immunol; 1990 Jan; 144(2):610-3. PubMed ID: 2295803
[TBL] [Abstract][Full Text] [Related]
56. AA amyloid fibrils from diseased tissue are structurally different from in vitro formed SAA fibrils.
Bansal A; Schmidt M; Rennegarbe M; Haupt C; Liberta F; Stecher S; Puscalau-Girtu I; Biedermann A; Fändrich M
Nat Commun; 2021 Feb; 12(1):1013. PubMed ID: 33579941
[TBL] [Abstract][Full Text] [Related]
57. Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2018 Sep; 93(9):1169-1180. PubMed ID: 30040145
[TBL] [Abstract][Full Text] [Related]
58. Fresh Frozen Versus Formalin-Fixed Paraffin Embedded for Mass Spectrometry Imaging.
Patel E
Methods Mol Biol; 2017; 1618():7-14. PubMed ID: 28523495
[TBL] [Abstract][Full Text] [Related]
59. Lipid membranes accelerate amyloid formation in the mouse model of AA amyloidosis.
Vahdat Shariat Panahi A; Hultman P; Öllinger K; Westermark GT; Lundmark K
Amyloid; 2019 Mar; 26(1):34-44. PubMed ID: 30929476
[TBL] [Abstract][Full Text] [Related]
60. Human SAA1-derived amyloid deposition in cell culture: a consistent model utilizing human peripheral blood mononuclear cells and serum-free medium.
Ishii W; Liepnieks JJ; Yamada T; Benson MD; Kluve-Beckerman B
Amyloid; 2013 Jun; 20(2):61-71. PubMed ID: 23461622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
